Skip to main content
Premium Trial:

Request an Annual Quote

Thrive Earlier Detection: Matt Franklin, Sarah Larson, Semi Trotto

Thrive Earlier Detection has announced the appointment of Matt Franklin as its chief commercial officer, the appointment of Sarah Larson to its board of directors, and Semi Trotto's promotion to chief people officer.

Franklin holds more than 20 years of business, commercial, and strategic marketing experience in the diagnostics, life sciences, and technology industries. Most recently, he served as chief business officer at ArcherDx, where he was responsible for various business development activities. Prior to Archer, he held senior leadership roles at both Foundation Medicine and Boston Scientific.

Larson currently serves as partner and chief human resources officer at Third Rock Ventures where she is responsible for human resources and also provides guidance and counsel to the firm's portfolio companies, focusing on areas of human capital, leadership development, and culture creation. She has more than 20 years of experience in human resources and leadership development.

Trotto, a member of Thrive's founding management team, most recently served as senior vice president and head of human resources. Before joining Thrive, she held leadership positions in human resources at Editas Medicine, Baxalta, and Bristol-Myers Squibb. She has more than 20 years of experience in the field overall.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.